NovaBay Pharmaceuticals, Inc. (NBY)
After hours:
| Previous close | 0.1200 |
| Open | 0.1500 |
| Bid | 0.1153 x 1200 |
| Ask | 0.1191 x 3000 |
| Day's range | 0.1052 - 0.2594 |
| 52-week range | 0.0700 - 1.2800 |
| Volume | |
| Avg. volume | 2,981,738 |
| Market cap | 4.487M |
| Beta (5Y monthly) | 2.04 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q1 2024 Earnings Call Transcript
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q1 2024 Earnings Call Transcript May 11, 2024 NovaBay Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, welcome to the NovaBay Pharmaceuticals Financial Results Conference Call. At this time, all participants […]
- Insider Monkey
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript March 26, 2024 NovaBay Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.95 EPS, expectations were $-0.3. NBY isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to […]
- Thomson Reuters StreetEvents
Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call
Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call
